Virus rubellae, vivum, attenuatum, Virus morbilli (stirps Schwarzi), vivum, attenuatum, Virus parotitidis epidemici, vivum, attenuatum
| Medicinal product name | Priorix powder and solvent for solution for injection |
|---|---|
| Pharmaceutical form | Powder and solvent for solution for injection |
| Strength | |
| Information from the MAH on shortages |
Not available predicted availability date: not notified |
| Legal status | Prescription (Pr.) |
| Package leaflet |  12-05-2022
|
| Summary of product characteristics | 12-05-2022
|
| ATC code | J07BD52 – Vaccines |
Medicinal products (6)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (1 deva) |
Glass vial and ampoule | 12-0227-01 |
Labelling text May 12, 2022 |
|
|
Not available (according to the information provided by wholesalers) predicted availability date: not notified |
currently no information on availability from any wholesaler |
N10 (1 deva) |
Glass vial and ampoule | 12-0227-02 |
Labelling text May 12, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (1 deva) |
Glass vial and ampoule | 12-0227-03 |
Labelling text May 12, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N25 (1 deva) |
Glass vial and ampoule | 12-0227-04 |
Labelling text May 12, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N40 (1 deva) |
Glass vial and ampoule | 12-0227-05 |
Labelling text May 12, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (1 deva) |
Glass vial and ampoule | 12-0227-06 |
Labelling text May 12, 2022 |
Registration information
| Marketing authorisation No. | 12-0227 |
|---|---|
| Date of authorisation | Oct 5, 2009 |
| Marketing authorisation holder, country | GlaxoSmithKline Biologicals S.A., Belgium |
